Cancer Genetics, Inc. To Promote FHACT™ Test For Cervical Cancer At American Congress Of Obstetricians And Gynecologists' Annual Clinical Meeting
Published: Apr 25, 2014
RUTHERFORD, N.J., April 25, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, will be participating in the Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG), being held April 26-30 at the McCormick Place Convention Center in Chicago, Illinois. ACOG is the premier gynecological conference in the U.S. The conference hosts more than 200 exhibitors, and features more than 400 original research posters and paper abstracts.
Help employers find you! Check out all the jobs and post your resume.